SE
Therapeutic Areas
Mainz Biomed Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ColoAlert® | Colorectal Cancer Screening | Pivotal Trial |
| ColoFuture | CRC & Advanced Adenoma Detection | Clinical Validation |
| Pancreatic Cancer Detection Test | Pancreatic Cancer Early Detection | Research |
| MCED Test | Multi-Cancer Early Detection | Research Collaboration |
Leadership Team at Mainz Biomed
GB
Guido Baechler
CEO & Director
WC
William Caragol
CFO
ME
Moritz Eidens
VP Research
DC
Dr. Chris von Törne
COO
TK
Tarrin Khairi-Taraki
V.P. Commercial Operations
RL
Robert Liscouski
Chairman of the Board
DH
Dr. Heiner Dreismann
Non Executive Director
HH
Hans Heskeland
Director
DS
Dr. Soren Thestrup-Nielsen
Clinical Advisor
DM
Dr. Michele Pedrocchi
Advisor